Newest Issue is Out. Get your exclusive copy today.
Research & Development is essential in all industries. And, when it comes to the Biopharmaceutical research industry, R&D services not only generates income for the companies involved in the research but it often brings results in lives being saved, or at least enhancement in patient's lives. The development for many companies requires the perfect Pharmaceutical research & development. There has been a great deal of research and development in this industry by the doctors and scientists all over the world. Reliable Pharmaceutical R&D services allow companies to follow manufacturing procedures, quality control measures being taken, production scope and technical know-how.
Drugs as small or mediumsized molecules nanometer in diameter typically possess both lipophilic and hydrophilic properties For a drug molecule to reach its intracellular target it usually needs to cross several barriers including mucus gel layer intestinal epithelial cells capillary endothelium and finally membrane of target cells
Nanotherapeutics is the branch of nanotechnology that deals with the application of nanoparticulate drug delivery systems to treat or manage diseases by specific delivery of a therapeutic agent to a targeted location in the body
In December a pneumonia outbreak occurred in Wuhan city of China that quickly spread across the world and posed serious public health emergency On January novel coronavirus severe respiratory disease syndrome coronavirus SARSCoV was identified as the cause of outbreak in Wuhan
Over the past year the COVID pandemic has heightened the urgency for clinical research to understand the disease uncover treatment plans and develop vaccines to treat a disease that was once unknown to the world It was equally crucial that findings were swiftly made available to the public to prevent misleading information from undermining the publ...
Transplantation is a compelling need in India and one that has few and very pricey providers mismatching the necessity The frequency of occurrence of congenital or acquired blood disorders which can be treated by Haematopoietic Stem Cell Transplantations HSCT and sometimes termed Bone Marrow Transplant or BMT is sufficiently large for a viable corp...
From mobile medical apps and fitness trackers to software that supports the clinical decisions that doctors make every day digital technology has been driving a revolution in healthcare As we learn to live in the new normal forced by the COVID pandemic adoption of digital solutions has witnessed further acceleration
Biomarkers or biological markers cover a wide range of substances that can be measured from body tissues cells blood or fluid For instance a cell expresses genes when they are required for biological processes and the measurement of gene expressions under different physiological conditions provide essential clues of gene functions Therefore bioma...
Nanotechnology has brought a revolution in the area of medicine and an exponential development was reported in the nanotechnology relatedpatents for the pharmaceutical applications in the past twenty years The pharmaceutical companies are deeply focused on the nanotechnology to overcome the drawbacks and find out the solutions for the challenges in...
As per the estimation of a Forbes analysis around US billion is spent by large pharmaceutical companiesfor a single drug approval
Conventional drug discovery path is arduous timeconsuming and demands massive fiscal investments
In the past few decades nanotechnology has emerged as one of the most important approaches for cancer diagnosis and therapeutics
Drug discovery is one of the most time and costconsuming processes in the industry
There is a rising opportunity for the pharma industry to consider developing products and administration devices for older age population The proportion of the elderly population is growing globally
Biologics are drugs isolated from natural sources and include proteins nucleic acids viruses and cells
The number of new US FDA approved drugs is declining in spite of lots advances made in science
For many drug discovery programmes HBS form the foundation of many hypotheses and contribute to research that is the basis for gonogo decisions during the development process
In the recent years Research Development RD in the area of nanoscience and nanotechnology has increased rapidly
Over the past few decades life science and pharma have been characterised by a series of radical changes that have been at the origin of an impressive transformation of RD processes and have made them a favoured scenario for radical change in the innovation paradigm
Diabetes Mellitus DM is a chronic lifethreatening disease just like cancer or any other disease whose incidence has become doubled in recent years In diabeties patients the use of intensive insulin therapy was found to reduce long term vascular complications and some evidence also highlights the increased risk of both hyperglycemia and hypoglycemia...
What are MCMs MCMs are regulated products that can be used in a public health emergency The emergency could be due to a terrorist attack with Chemical Biological Radiological Or Nuclear CBRN material a naturallyoccurring emerging disease or a natural disaster MCMs can be used to prevent diagnose or treat conditions resulting from those natural o...
In the recent decades most of the pharmaceutical companies often look for extensions for their patented product to enhance the products life cycle by means of various approaches like a Drug repurposing ie new indication of existing drug b Using different formulation ie by means of using new and novel drug delivery technologies and c Use of new comb...
Drug Hypersensitivity Reactions DHRs belong to type B adverse drug reactions defined by the World Health Organisation WHO as doseindependent unpredictable noxious and unintended response to a drug at dose normally used in humans They include drug intolerance drug idiosyncrasy drug allergy and nonallergic anaphylactic reaction Most of type B reactio...
By definition biology is the natural science while biotechnology utilises biological systems and living organisms to develop different products A product could be an article or substance or technology that is manufactured or refined or developed for sale for sure The list of biotechnological products broadly includes medicines medical devices diagn...
RD has traditionally been and will continue to be probably even more crucial for the growth and future success of researchbased pharma companies Given the industries traditional RD strategy that was built on internal innovation and the rising regulatory hurdles pharma companies continuously increased their financial input into RD related work with...
This years the interest in stem cell and genebased therapy showed from industries and spinout companies have been exceptional which reflects the growing confidence in the field grounded on frequently reports of the therapeutic efficacy and the licensing of stem cell and genebased therapies Yet stem cellbased therapy remains in its early stages akin...
The difficulty of getting reimbursement in the US for novel therapeutics especially ones based on innovative new technology platforms renders such products less available in AsiaPacific as well Fully half of new active substances NASs approved globally each year ownership of the extant RD pipeline worldwide and the endmarket for all medicines are i...
The government and research academics are increasingly aware of the relevance of their result to the industrial sector The term knowledge translation was coined to represent proactive strategies to communicate research findings to those in a position to put the findings into practice As it happens in most cases the first consideration is given to m...
As the pharmaceutical market expands and new technologies and actives are adopted selecting the right excipient is essential to achieve optimum performance and functionality in pharmaceutical formulations and in particular in capsules todays consumer preferred dosage form The global markets for empty hard and soft capsules are expected to grow sign...
It is common knowledge that drug discovery is a tough business to be in and requires constant questioning as well as refining of ongoing strategies In this game the early days were rewarding for those employing the classical approaches that rely upon identifying the target and building a programme around these wellestablished targets to produce nov...
The removal of cells and cell debris takes place between fermentation upstream and product purification downstream and is referred to as midstream The midstream process very often involves a combination of several operation units A highly efficient method for this is alluvial filtration cake filtration and can be done with FILTRODISC BIO SD Cont...
Using stem cells as platforms for drug discovery not only allows us to recreate the microenvironment usually found inside the body but it also allows us to decipher the molecular intricacies that play an important role in the success of precision medicine and ways to further improve it Traditional drug discovery practice includes the early phase...
The protein drugs constitute almost everything of the biopharma today This include signalling proteins eg insulin erythropoietin monoclonal antibodies eg Bevacizumab Rituximab that are used as drugs peptide drugs eg Liraglutide Icatibant antibodydrug conjugates eg Trastuzumab emtansine modern recombinant protein vaccines eg Tetanus toxoid etc The p...
As Sir Winston Churchill one famously stated Those who fail to learn from history are doomed to repeat it That statement certainly holds true for the drug development industry Researchers who cannot learn from a new drug candidates complete historyboth good and badwill not make the best most informed decisions about its future Knowledg
Over the past decade a plethora of comments have highlighted a decline in Pharma RD productivity Several causes have been claimed including tighter regulation leading to even higher attrition as well as increasing costs Another explanation has been that the biological targets against which drugs are designed have become more challenging In other wo...
Beginning in the mids incidents involving easily we aponised and accessible agents such as anthrax a commonly occurring bacterium and sarin a chemical toxin from a commonly used family of pesticides demonstrated the growing threat of Chemical Biological Radiological and Nuclear CBRN agents as weapons for bioterror attacks At the same time there was...
Up until a few years ago the field of medicine was largely dominated by small molecules or pharmaceuticals as they are more commonly known Large molecules or biologics were relatively less heard of and there were very few players operating globally in this area Over the past two decades the biotechnology industry has come a long way According to a...
It costs approximately US billion yuan to bring a single new drug to marketand the cost as well as the hurdles to innovation are getting higher Yet innovation is crucial to the pharmaceutical industry and the need for a strong product pipeline is sending companies racing to develop some of the most promising new treatmentsbiologicsin the hope of d...
With over two decades of experience within the realm of Drug Development behind you what are the milestones of your career journey that you would like to share with us Last two decades was really wonderful and exciting journey working in drug development industry Though I cannot claim but have experienced almost entire process of drug developme...
Programs to identify and evaluate novel therapeutic agents are expensive take a long time and do not guarantee a successful outcome Proving safety and efficacy is difficult complex and slow Furthermore even after efficacy and safety are demonstrated and the compound becomes a medicinal product the complexities of disease and of the drug action alli...
Ion channels have been excellent drug discovery targets for decades with clinically meaningful drugs identified targeting sodium channels including eg lamotrigine calcium channels eg amlopdipine GABA receptors eg diazepam and ATPgated potassium channels eg glipizide and several others However new ion channel modulators have not been emerging at a r...
Poorly soluble new drugs entering the market are estimated to range from to per cent of the total This trend of increased poorly soluble drugs on the market is a result of the quest for drugs with increased potency and increased ability to interact with protein receptors The advent of modern drug discovery techniques such as quantitative structur...
Discovering and developing a new drug is a costly and timeconsuming process Recent reports suggest that it costs around US million pretax to bring a new drug to market One approach to improve the efficiency and lower the cost of this process is to use appropriate models and assays early in the discovery phase to identify candidates that are likely...
Human diseases not only impair bodily structures and functions but they also threaten the health and wellbeing of humans Current research on diseases focusses mainly on the microbiological immunological and pathological aspects rather than on the biomechanics of the diseases which may have direct link to their pathophysiological outcomes In fact so...
Drug discovery is a tough business At the same time it is the domain that provides an opportunity to improve the quality of human health and allows recovering from the suffering due to various biological disorders In the past decades we have witnessed a major limitation in creating the nextgeneration drugs despite a significant boost in the fina...
The desired features of pharmaceutical drug delivery for intravenous administration their small size biodegradability high content of a drug in a final preparation prolonged circulation in the blood and the ability to target required areas are reasonably well met by liposomes microcapsules and nanoparticles for watersoluble drugs The development of...
Since layerbylayer LbL polyelectrolyte assembly was introduced in the s by G Decher Y Lvov H Mhwald and M Rubner it has found application in various fields that study and apply nanotechnology LbL nanoassembly is based on the sequential adsorption of positively and negatively charged polymers on a surface to form a nanothick film of coating The proc...
Pele ChoiSing Chong The pharmaceutical industry now operates in a complex and dynamic global environment The pace of change is much faster and far less predictable than ever before To survive and prosper in todays business environment we need to
Over the past decade there has been increasing pressure on the pharmaceutical industry to increase economic efficiencies in drug discovery This has been driven by several factors including the increased costs of RD lower productivity patent expiration generic competition and the increasing difficulty in bringing new chemical entities to market T...
While the growing demand for innovative medicines is creating increasing opportunities for the pharmaceutical industry it is exactly this industry that suffers from an expensive disease itself known by the name innovation deficit In fact while the FDA approved New Molecular Entities NMEs and biologics in a nearly steady decline since then has led...
Many of the blockbuster biological products that currently dominate the markets are coming to the end of their patent protection The opportunity to provide more affordable generic versions is now attracting the interest of both generic and researchbased pharmaceutical companies The development of generic biological medicines referred to as
